Companies / BMY vs ABBV
BMY vs ABBV: Bristol Myers Squibb and AbbVie
Bristol Myers Squibb (BMY) reported $48.2B in revenue against a 14.6% net margin, while AbbVie (ABBV) reported $61.2B at a 6.9% net margin, most recently.
| Metric | BMY | ABBV |
|---|---|---|
| Revenue | $48.2B | $61.2B |
| Net Income | $7.1B | $4.2B |
| Gross Margin | 71.1% | 70.2% |
| Operating Margin | 19.4% | 24.6% |
| EPS (Diluted) | $3.46 | $2.36 |
| Free Cash Flow | $12.8B | $17.8B |
| Total Debt | $47.1B | $67.0B |
| P/E Ratio | 15.6× | 96.8× |
| P/B Ratio | n/m | n/m |
| Stock Price | $63.16 | $288.14 |
Free: last 5 years
| Fiscal year | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $46.4B | $46.2B | $45.0B | $48.3B | $48.2B |
| ABBV Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $56.2B | $58.1B | $54.3B | $56.3B | $61.2B |